Single-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Cytochrome P450 Interaction Study of LY3154207 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 20 Oct 2015
At a glance
- Drugs LY 3154207 (Primary) ; Itraconazole
- Indications Unspecified
- Focus Adverse reactions
- Sponsors Eli Lilly
- 10 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 May 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 05 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.